Abstract
Introduction
Acute myocardial infarction (MI) remains a leading cause of death worldwide. It is most often a result of atherosclerotic plaque disruption (erosion or rupture), accompanied by thrombus formation that results in obstruction of blood flow, tissue ischemia and necrosis [1] . Although significant advancements have been made using biomarkers and electrocardiograms (ECGs) to diagnose acute MI, these methods measure the end result (i.e., myocardial necrosis) and not the cause and therapeutic target, coronary thrombosis. There are several common non-thrombotic causes of MI (e.g., demand ischemia, stress cardiomyopathy), with varying therapeutic and prognostic implications [2] . Hence, these measurements cannot distinguish tissue necrosis caused by coronary thrombosis from other causes of necrosis such as demand ischemia or stress cardiomyopathy [2] . Even in the most fulminant manifestation of MI, acute ST-elevation MI (STEMI), 14% of subjects have no identifiable culprit lesion on angiography when conservatively defined as no lesion with > 70% stenosis [3] . Additionally, while circulating levels of cardiac proteins such as cardiac troponin are specific indicators of myocardial necrosis, the levels of these proteins often do not increase for several hours subsequent to the initial acute MI delaying diagnosis [4] . Therefore, current diagnostic criteria for acute MI often fail to confirm the diagnosis prior to the induction of irreversible myocardial necrosis, even with highly sensitive cardiac troponin assays [5] .
Coronary angiography remains the standard diagnostic tool for evaluating patients suspected of acute coronary thrombus. The third universal definition of acute MI identifies angiographic confirmation of coronary thrombus as a criterion for the diagnosis of acute MI [6] . However, there is limited data available concerning the sensitivity and specificity of angiography for presence or absence of coronary thrombus.
The goal of the present study is to evaluate the utility of five commonly used angiographic characteristics (Ambrose complex lesion morphology; spherical, ovoid, or irregular filling defect; abrupt vessel cutoff; intraluminal staining; and any coronary filling defect) in identifying the presence of an acute coronary thrombus in 80 subjects with acute MI or stable coronary artery disease (CAD) undergoing coronary angiography.
Methods

Study design and population
Between March 2012 and September 2013, 80 acute MI or stable CAD patients (Supplemental Table 1 -see journal website) undergoing coronary angiography at KentuckyOne Health Jewish Hospital or the University of Louisville Hospital (Louisville, Kentucky, United States) were prospectively enrolled in the study prior to coronary angiography. Patients who received fibrinolytic therapy prior to coronary angiography were not eligible. The study protocol was approved by the institutional review board and all subjects provided informed written consent. All ECGs were systematically evaluated according to established criteria by a single board-certified cardiologist [6] [7] [8] [9] .
Coronary angiography
Angiograms were systematically evaluated in all subjects by an experienced team of one technician and one board certified interventional cardiologist, blinded to all other subject data. All reported values represent a consensus opinion from the Angiographic Core Laboratory, Johns Hopkins University (Baltimore, Maryland). Angiographic scoring (Supplemental Figure 1 -see journal website) was developed prior to assessment, to include the evaluation of angiographic characteristics reported in the literature (Supplemental Figure 2 -see journal website) for detection of a coronary thrombus [10] [11] [12] [13] [14] [15] [16] [17] [18] . The presence of following five angiographic characteristics were defined a priori as independent variables: 1) complex Ambrose lesion morphology (Fig. 1A) [12, 19] ; 2) spherical, ovoid, or irregular intramural filling defect (Fig. 1B) [13] ; 3) abrupt vessel cutoff with persistence of contrast (Fig. 1C) [16] ; 4) intraluminal staining (Fig. 1D) [18] ; 5) any coronary filling defect (includes spherical, ovoid, irregular, hazy, or occlusive filling defects and obstructive coronary dissections) (Fig. 1E) [19] . Lesions may have one or more of the aforementioned angiographic characteristics.
Determination of individual lesions
Individual lesions were defined as lesions in a distinct vessel branch or separated by > 3 cm of normal vessel (< 10% stenosis). The most severe portion of the lesion was used for grading the lesion. All lesions with ≥ 10% stenosis were evaluated. Lesion numbers were recorded on the basis of their location on the 29-segment coronary artery map (Supplemental Figure 3 -see journal website) [17] . The ramus intermedius was considered to be part of the left anterior descending coronary artery territory.
Histological and biochemical analysis
The standard of care at the enrollment sites was to attempt coronary aspiration thrombectomy when an acute coronary thrombus was suspected. Aspiration thrombectomy was left to the discretion of the treating interventional cardiologist. All aspiration thrombectomy attempts were immediately filtered and preserved in formalin for histological evaluation by a pathologist at CVPath, Inc. (Gaithersburg, Maryland) blinded to all other data. Ortho Vitros 5600 assay at the University of Louisville Hospital and Beckman Access assay at the KentuckyOne Health Jewish Hospital, were used to measure troponin levels and confirm the diagnosis of acute MI. Troponin criteria for outcomes are detailed in the supplement (Supplemental Methods, Biochemical Datasee journal website).
Outcome groups
Lesions from each subject were categorized into three outcome groups (Table 1) . Group 1 consisted of lesions with histologically confirmed thrombus (£ 4 days old). Group 2 consisted of lesions that were highly probable to contain coronary thrombus -lesions with histologically confirmed thrombus £ 4 days old (all lesions in Group 1) PLUS lesions with > 70% stenosis and corresponding elevated troponin and ST-segment elevation on the ECG in territory of the vessel. Group 2 was created to mitigate for the selective coronary aspiration thrombectomy in our cohort and the potential failure of aspiration thrombectomy to capture an existing thrombus [20] . Group 3 consisted of lesions highly unlikely to have a coronary thrombus -no histologically confirmed thrombus recovered, no troponin elevation AND no ST-segment elevation or depression on the ECG. 
Ethics statement
Informed and signed consent was obtained for all subjects enrolled and this study was approved by the University of Louisville's Institutional Review Board. This submission complies with the ICMJE ethics and STROBE guidelines.
Statistical analysis
The primary outcome of this study was based on a lesion-level analysis of angiographic characteristics for the detection of thrombotic lesions. Frequencies, percentages, and Fisher's exact test p-values are reported for comparing categorical characteristics between subject groups. Means, standard deviations, and p-values from Student t-test or Wilcoxon rank-sum tests (as appropriate) are reported for comparing continuous characteristics between groups.
In the case of a zero-count (or very low event count) of characteristic(s) in the cell, an absolute relationship would be established between the characteristic(s) and the occurring group, and therefore the odds would not be computable [21] . Under these conditions, conservative odds ratio estimates would be generated by adding one event to the zerocount (or very low event count) cell of the group.
Primary endpoints
The primary endpoints of this study were the independent association of the presence of angiographic characteristics with the three studydefined outcome groups. This evaluation was accomplished by comparing the frequencies of angiographic characteristics in lesions with histologically confirmed thrombus (Group 1) vs. all lesions without histologically confirmed thrombus (Not-Group 1); lesions highly probable to contain coronary thrombus (Group 2) vs. all lesions not highly probable of having a thrombus (Not-Group 2) and lesions highly unlikely to have a coronary thrombus (Group 3) vs. all lesions not highly unlikely to have a thrombus (Not-Group 3). These analyses are further described in the supplement (Supplemental Methods, Primary Endpoints -see journal website). Lesions in Group 1 or Group 2 were considered as thrombotic lesions and lesions in Group 3, Not-Group 1 or Not-Group 2 were considered as non-thrombotic lesions.
Results
Angiograms were analyzed for all 80 subjects enrolled in the study. Four subjects did not have any lesions with ≥ 10% stenosis and therefore did not qualify for lesion analysis; these subjects had non-thrombotic MI presentations (e.g., demand ischemia). Seventy-six subjects had a total of 323 individual lesions (≥ 10% stenosis). A total of 27 thrombus aspirations were attempted from distinct lesions, of which 23 (85%) were confirmed as thrombus on histopathology (Group 1). Thirty subjects had a total of 73 lesions that qualified for Group 2, and 18 subjects had a total of 61 lesions that qualified for Group 3. The clinical characteristics of the subjects in this cohort are presented in Table 2 .
Complex Ambrose morphology
Complex Ambrose morphology was not associated with histologically confirmed coronary thrombus (Group 1 vs. Not-Group 1, p > 0.5), highly probable coronary thrombus (Group 2 vs. Not-Group 2, p > 0.5), nor was the absence of complex Ambrose morphology associated with absence of coronary thrombus (Group 3 vs. Not-Group 3, p > 0.5, Tables 3-5 ).
Spherical, ovoid or irregular filling defect
Spherical, ovoid, or irregular filling defect was present in 39% of histologically confirmed thrombotic lesion (Group 1) as compared to 1% of lesions without a histologically conformed thrombus (Not-Group 1) (OR = 206, 95% CI 36.5-1161, p < 0.0001, Table 3 ). Similarly, it was present in 14% of lesions that were highly probable for coronary thrombus (Group 2) as compared to < 1% of lesions that were not highly probable for coronary thrombus (Not-Group 2) (OR = 60.8, 95% CI 3.84-961, p = 0.004, Table 4 ). Spherical, ovoid, or irregular filling defect was not present in any lesions classified as highly unlikely to have a coronary thrombus (Group 3) ( Table 5) . Spherical, ovoid, or irregular filling defect was 22-55% sensitive and 99-100% specific for histologically confirmed or lesions highly probable for coronary thrombosis (Tables 3, 4) .
Abrupt vessel cutoff with persistence of contrast
Abrupt vessel cutoff with persistence of contrast was present in 61% of histologically confirmed thrombotic lesions (Group 1) as compared to 8% of lesions without a histologically confirmed thrombus (Not-Group 1) (OR = 18, 95% CI 6.64-49.1, p < 0.0001, Table 3 ). Abrupt vessel cutoff was present in 27% of lesions highly probable to have a thrombus (Group 2) as compared to 7% of lesions not highly probable for a coronary thrombus (Not--Group 2) (OR = 3, 95% CI 1.12-6.57, p = 0.03, Table 4 ). Abrupt vessel cutoff was present in 2% of lesions highly unlikely to have a coronary thrombus (Group 3) ( Table 5 ). Abrupt vessel cutoff was 32-59% sensitive and 92-94% specific for histologically confirmed or lesions highly probable for coronary thrombus (Tables 3, 4) . Elevated troponin -Ortho Vitros 5600 assay = 0.12 ng/mL and Beckman Access assay = 0.5 ng/mL § Non-elevated troponin -Ortho Vitros 5600 assay £ 0.035 ng/mL and Beckman Access assay £ 0.04 ng/mL
Intraluminal staining
Intraluminal staining was present in 35% of lesions with histologically confirmed thrombus (Group 1) as compared to 1% of lesions without histologically confirmed thrombus (Not-Group 1)
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Intraluminal staining was present in 12% of lesions highly probable for a coronary thrombus (Group 2) as compared to 1% of lesions not highly probable for a coronary thrombus (Not-Group 2) (OR = 8, 95% CI 2.12-31.6, p = 0.002, Table 4 ). Intraluminal staining was absent in all lesions highly unlikely to have a coronary thrombus (Table 5) . Intraluminal staining was 17-36% sensitive and 99% specific for histologically confirmed or lesions highly probable for coronary thrombus (Tables 3, 4) .
Any coronary filling defect
Any coronary filling defect was present in 48% of lesions with histologically confirmed thrombus (Group 1) as compared to 3% of lesions without histologically confirmed thrombus (Not-Group 1) (OR = 69, 95% CI 20.4-234, p < 0.0001, Table 3 ). Any coronary filling defect was present in 19% of lesions highly probable for a coronary thrombus (Group 2) and 2% of lesions not highly probable for a coronary thrombus (Not-Group 2) (OR = 9, 95% CI 2.7-26.9, p = 0.0002, Table 4 ). Any coronary filling defect was present in 2% of lesions highly unlikely to have a coronary thrombus (Group 3) ( Table 5 ). Any coronary filling defect was 26-60% sensitive and 97-98% specific for histologically confirmed or lesions highly probable for coronary thrombosis (Tables 3, 4) .
Discussion
In this prospective study of 80 subjects with acute MI or stable CAD undergoing coronary angiography, there were four major findings with important clinical implications. First, Ambrose morphology failed to differentiate between thrombotic and non-thrombotic lesions. Second, the remaining four characteristics (spherical, ovoid, or irregular filling defect; abrupt vessel cutoff; intraluminal staining; and any coronary filling defect) were consistently more common and highly specific (92-100%) for thrombotic vs. non-thrombotic lesions. Third, spherical, ovoid, or irregular filling defect and intraluminal staining had highest specificities (99-100%) for the presence of a thrombotic lesion. Fourth, spherical, ovoid, or irregular filling defect and intraluminal staining were present in < 40% of all thrombotic lesions, hence a high specificity (99-100%) but low sensitivity (£ 55%) for identifying coronary thrombus in this cohort. Thus, in the right clinical context, their presence is highly suggestive of coronary thrombus, while their absence does not rule out an acute coronary thrombus.
Although the five characteristics evaluated in this study have been ubiquitous in the angiographic literature for decades [12, 13, 16, 18, 19] , validation studies against histological confirmation of thrombus are limited. In a post-mortem study of lesion morphology, Levin et al. [22] , found that 79% of lesions consistent with complex Ambrose lesion morphology were associated with "complicated" histology, which were comprised of plaque rupture and or hemorrhage without thrombosis. However, that study was limited by the unknown time between death and post-mortem coronary angiography in addition to the fact that angiography differs between post-mortem and a live-beating heart. The association between Ambrose complex lesion morphology and unstable angina has been described [10, 12, [23] [24] [25] [26] . Recently, Ambrose et al. [27] reported that there exists an association between complex morphology and thrombotic/Type 1 MI, rather than non-thrombotic/Type 2 MI, which is consistent with previous reports that complex lesions represent ruptured atherosclerotic plaque, partially occlusive thrombi, or both [26] . However, when superior imaging modalities like angioscopy or intravascular ultrasound (IVUS) are used to validate the presence of a coronary thrombus, the specificity of complex Ambrose morphology for identification of a coronary thrombus is limited [28] [29] [30] . In our study, we did not find a significant relationship between complex Ambrose morphology and acute coronary thrombosis (Group 1 or Group 2 lesions). Ambrose morphology criteria www.cardiologyjournal.org may be better suited for identifying lesions associated with myocardial ischemia [16, 29] , rather than for confirmation of an acute coronary thrombus. Rehr et al. [31] defined intracoronary thrombus as presence of abrupt vessel cutoff with contrast persistence and intraluminal filling defect to differentiate unstable angina from stable angina. They found that the sensitivity for detecting a thrombus in the unstable angina group was low (42%) and the specificity was moderate (83%). Both of these characteristics were evaluated, i.e. abrupt vessel cutoff with contrast persistence and any coronary filling defect, individually in this study it was found that although the sensitivity of both the characteristics to identify thrombotic lesions was also low (26-60%), their specificity to identify thrombotic lesions was high (92-98%).
DeWood et al. [28] studied angiographic detection of coronary thrombus in 79 STEMI patients undergoing emergent surgical revascularization and found that 75% of patients had persistent angiographic intraluminal staining, and 88% of those with intraluminal staining had a thrombus recovered. These results are similar to findings in our study wherein intraluminal staining was present in significantly higher number of thrombotic lesions (Group 1 or Group 2) than non-thrombotic lesions (Not-Group 1 or Not-Group 2). Mabin et al. [32] used the presence of intraluminal filling defect and intraluminal staining as key criteria for detecting intracoronary thrombus in patients undergoing percutaneous angioplasty. In the study by Mabin et al. [32] , out of the 15 patients angiographically diagnosed with an intracoronary thrombus, 11 (73%) were confirmed to have coronary thrombus via emergent surgical intervention (coronary artery bypass grafting). The presence of both these characteristics, i.e. any filling defect and intraluminal staining, in the histologically confirmed thrombus group (Group 1) of our study was low (£ 48%). However, the specificity of intraluminal staining for thrombotic lesions (Group 1 or Group 2) was high (99%).
A spherical, ovoid, or irregular filling defect and intraluminal staining were found almost exclusively in groups with thrombotic lesions. However, both of these characteristics were present in fewer than 40% of all thrombotic lesions (Group 1 and Group 2), hence good specificity (99-100%) but poor sensitivity (£ 55%) for identifying coronary thrombus in the present cohort. Both of these characteristics were significantly associated with thrombotic lesion groups (Group 1 or Group 2) and only rarely with non-thrombotic lesion groups (Group 3, Not-Group 1, Not-Group 2). Therefore, the presence of either of these angiographic characteristics holds great promise for aiding in the diagnosis of coronary thrombus and warrants validation in an independent cohort. On the other hand, their absence does not rule out coronary thrombus in the right clinical context.
Limitations of the study
There is no gold standard for identifying the presence of a coronary thrombus except nearimmediate autopsy, which is only applicable to a select group of patients who die shortly after coronary angiography. Post-mortem angiography is of questionable relevance. In this study, standard-of-care coronary aspiration thrombectomy was employed, however, the decision to perform thrombectomy and the ensuing technique was left to the discretion of the interventional cardiologist [33, 34] . Furthermore, coronary aspiration thrombectomy may fail to capture thrombi in some cases [20] . Therefore criteria was introduced for the diagnosis of coronary thrombus that included histologically confirmed thrombus (Group 1) or a combination of electrocardiographic (ST-segment elevation), biochemical (elevated troponin) and coronary stenosis (> 70%) criteria (Group 2). Other techniques available for the identification of thrombi that were not employed in this study include IVUS, optical coherence tomography, and angioscopy; however, these techniques are limited by availability, the inability to cover the entire epicardial coronary circulation, and the limited amount (or total lack) of validation data with histologically confirmed thrombi [35, 36] .
Finally, this was not a study of all patients undergoing cardiac catheterization, but rather of a group of select patients with acute MI or stable CAD. Therefore, further study is required in the applicability of our findings to all patients suspected of acute MI undergoing coronary angiography.
Conclusions
Four of the five angiographic characteristics evaluated in this cohort were associated with acute coronary thrombus, as defined by histological analysis or a combination of histology, ST-segment elevation, troponin elevation and coronary stenosis. The presence of either spherical, ovoid, or irregular filling defect or intraluminal staining is highly specific (99-100%) for the presence of thrombotic lesions but these characteristics were present in < 40% of thrombotic lesions and therefore are not sensitive (£ 55%) for identifying coronary thrombus. Validation of these findings in an independent cohort to establish whether these characteristics can be used to help establish the diagnosis of acute coronary thrombus in clinical practice is warranted.
